Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

272.45 +2.81 (+1.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Amgen Stops Phase 1 For One BiTE Molecule While Resuming Dosing For Another, Plans Second Drug Substance Plant
During the latest quarterly update, Amgen Inc (NASDAQ: AMGN) disclosed that it is resuming dosing for pavurutamab (AMG 710) but halted enrollment to a trial for AMG 427... 
Via Benzinga
Amgen Q2 Profit Falls On Five Prime Acquisition Related Write-Off, Disputes IRS Claim On Owing $3.6B In Taxes
Amgen Inc said it received notices from the IRS looking to increase its federal tax bill by $3.6 billion, plus interest, for 2010, 2011, and 2012. 
Via Talk Markets
Amgen Q2 Profit Falls On Five Prime Acquisition Related Write-off, Disputes IRS Claim On Owing $3.6B In Taxes
Amgen Inc (NASDAQ: AMGN) said it received notices from the IRS looking to increase its federal tax bill by $3.6 billion, plus interest, for 2010, 2011, and 2012. The... 
Via Benzinga
Amgen inc (AMGN) Q2 2021 Earnings Call Transcript
AMGN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Amgen Q2 Earnings
Shares of Amgen (NASDAQ:AMGN) moved higher by 1.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 3.06% over the past... 
Via Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
Exposures COVID-19
Where Amgen Stands With Analysts
Within the last quarter, Amgen (NASDAQ:AMGN) has observed... 
Via Benzinga
Amgen Stock Dips Despite Second-Quarter Beat, Guidance Reiterated
Amgen stock dipped late Tuesday after reporting adjusted income of $4.38 per share on $6.53 billion in second-quarter sales. 
Via Investor's Business Daily
Dow Jones Jumps Back Above 35,000 -- This Could Push It Back to Record Levels Soon
The Dow Jones is knocking on record levels again, and positive earnings from some of its most popular components could be the catalyst to get it there. 
Via The Motley Fool
Topics Stocks
Exposures COVID-19 US Equities
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on Chinese stocks like TCEHY stock and BABA stock following new crackdowns. 
Via InvestorPlace
Dogs Of The Dow Lose Ground To Market Since First Quarter
The Dow Dogs remain in the performance derby with five months left in 2021. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Another Big Earnings Week Ahead
After a monumental week of Big Tech earnings, we're in for more than a quarter of S&P 500 companies' reports, including those from Alibaba (NYSE: BABA), General Motors... 
Via Benzinga
Topics Stocks
Exposures US Equities
Carter Worth And Mike Khouw's Amgen Trade
Carter Worth and Mike Khouw teamed up on CNBC's "Options Action" to give the viewers a bearish trade in Amgen, Inc. (NASDAQ: AMGN) ahead of earnings. Worth analyzed... 
Via Benzinga
3 Must-Own Healthcare Stocks For Your Portfolio
Healthcare stocks have had a steady run so far this year, with the industry’s growth prospects—based on ongoing digitization to revolutionize and increase demand—motivating investors. Thus, we believe... 
Via Talk Markets
Healthcare Stock Sell-Off Keeps the Dow Jones From Reaching Record Levels
A handful of healthcare giants are some of the few Dow stocks in the red so far today, as federal data underpins the prospects of a continued economic recovery. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Amgen Buys Antibody Player Focused On PSMA In $2.5B Deal
Amgen Inc (NASDAQ: AMGN) has agreed to acquire privately-held Teneobio, a biotechnology company developing a new class of biologics called Human Heavy-Chain... 
Via Benzinga
Dissecting the Dow Jones – 10 Attractively Valued Stocks
Only 10 of 30 stocks are attractively valued blue-chip stocks making up the Dow Jones Industrial Average (DJIA) today. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Healthcare ETFs in Focus as Q2 Earnings Unfold
Let’s dig deeper into the earnings picture of the companies which will drive the performance of healthcare funds in the coming days. 
Via Talk Markets
How To Find Value Stocks July 2021
Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value. 
Via Talk Markets
Benchmarks Extend Gains Amid Strong Day for Earnings
The Dow closed 286 points higher today, erasing Monday's sell-off as reopening stocks continue to climb, while the S&P 500 and Nasdaq finished the day in the black as well. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Boeing And Chevron Soar As The Dow Jones Finishes Higher
U.S. indices were trading higher as stocks continue to rebound following Monday’s weakness and as investors weigh recent earnings. Inves... 
Via Benzinga
Topics Stocks
Exposures US Equities
Moderna Stock — Soon To Join S&P 500 — Rockets To Yet Another Record
Moderna stock rocketed to another record high Friday on news it would join the S&P 500 on Wednesday, replacing soon-to-be-acquired Alexion. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions
Ahead of Thursday's meeting of the FDA's Cardiovascular and Renal Drugs Advisory Committee, the agency is raising fresh doubts on the safety of AstraZeneca Plc's... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
BeiGene-Amgen's Kyprolis Gets Approval In China For Pre-Treated Multiple Myeloma Patients
The China National Medical Products Administration (NMPA) has conditionally approved Kyprolis (carfilzomib) for relapsed or refractory (R/R) multiple myeloma. The... 
Via Benzinga
How Does Amgen's Debt Look?
Over the past three months, shares of Amgen (NASDAQ:AMGN) moved lower by nan%. Before having a look at the importance of debt, let us look at how much debt Amgen has. Amgen... 
Via Benzinga
Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA
The FDA has accepted for review Amgen Inc's (NASDAQ: AMGN) marketing application seeking approval for tezepelumab to treat asthma. Amgen is developing... 
Via Benzinga
Exposures Product Safety
Here's Why Biohaven Pharmaceutical Is Soaring Today
Preliminary sales figures for the company's new migraine drug were much better than expected. 
Via The Motley Fool
Exposures Product Safety
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop. 
Via Investor's Business Daily
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.